Armin Gerger
机构: Medical University of Graz
每年引用次数
引用次数
引用: 11,100
H-指数: 61
I10-指数 : 160
出版物: 448
Reply: Comment on'Elevated preoperative neutrophil
J SZKANDERA , M PICHLER , A GERGER , A LEITHNER
British journal of cancer 108 ( 12)
2013
Novel oxides and reliability for the passivation of AlGaN
BP GILA , AH ONSTINE , M HLAD , A GERGER
Proceedings-Electrochemical Society 247 -261
2005
Discrimination of benign common nevi from malignant melanoma lesions by use of features based on spectral properties of the wavelet transform.
Josef Smolle , Marco Wiltgen , Patrick Bergthaler , Armin Gerger
Analytical and Quantitative Cytology and Histology 25 ( 5) 243 -253
6
2003
MicroRNAs in renal cell carcinoma: implications for pathogenesis, diagnosis, prognosis and therapy.
Anna Lena Ress , Martin Pichler , Armin Gerger , Bader Mohamad Al-Ali
Anticancer Research 32 ( 9) 3727 -3732
33
2012
The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer.
Hellmut Samonigg , Melanie Weissmueller , Gudrun Absenger , Wilfried Renner
Anticancer Research 32 ( 8) 3473 -3478
3
2012
MicroRNAs in testicular cancer: implications for pathogenesis, diagnosis, prognosis and therapy.
Martin Pichler , Angelika Bezan , Armin Gerger
Anticancer Research 34 ( 6) 2709 -2713
35
2014
Molecular Predictors of Combination Targeted Therapies (Cetuximab, Bevacizumab) in Irinotecan-Refractory Colorectal Cancer (BOND-2 Study)
Pierre Bohanes , Georg Lurje , Yan Ning , Ellen Hollywood
Anticancer Research 30 ( 10) 4209 -4217
31
2010
An automated method for the quantification and fractal analysis of immunostaining
Josef Smolle , Patrick Bergthaler , Armin Gerger
Analytical Cellular Pathology 26 ( 3) 125 -134
6
2004
Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future
Johannes Haybaeck , Tobias Kiesslich , Marc D. Bullock , Michael Stotz
Anticancer Research 35 ( 11) 5737 -5744
53
2015
Association of Hypoxia-inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis
Uwe Langsenlehner , Dadbeh Dehchamani , Hellmut Samonigg , Wilfried Renner
Anticancer Research 30 ( 6) 2393 -2397
17
2010
Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients.
Uwe Langsenlehner , Hellmut Samonigg , Gudrun Absenger , Wilfried Renner
Anticancer Research 31 ( 4) 1373 -1377
4
2011
Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome in Patients with Stage II and III Colon Cancer
Hellmut Samonigg , Gudrun Absenger , Anna Lena Ress , Joanna Szkandera
Anticancer Research 33 ( 10) 4591 -4594
40
2013
Computer-aided diagnosis of melanocytic skin tumors by use of confocal laser scanning microscopy images.
Josef Smolle , Marco Wiltgen , Silvia Koller , Marcus Bloice
Analytical and Quantitative Cytology and Histology 33 ( 2) 85 -100
6
2011
Evaluation of texture features in spatial and frequency domain for automatic discrimination of histologic tissue.
Josef Smolle , Marco Wiltgen , Patrick Bergthaler , Armin Gerger
Analytical and Quantitative Cytology and Histology 29 ( 4) 251
11
2007
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Gerald Hoefler , Ellen Heitzer , Herbert Stöger , Martin Pichler
Therapeutic Advances in Medical Oncology 13 1758835920987658 -1758835920987658
4
2021
Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Barbara Prietl , Andreas Leithner , Bernadette Liegl-Atzwanger , Amin El-Heliebi
OncoImmunology 10 ( 1) 1896658 -1896658
2021
Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Richard Greil , Angela Djanani , Herbert Stöger , Konstantin Schlick
European Journal of Cancer 151 3 -13
2021
Soluble CD87 (s-uPAR) predicts bevacizumab-based first line treatment of metastatic colorectal cancer (mCRC): Results from a prospective multi-center study.
Matthias Unseld , Gabriele Kornek , Andreas Gleiss , Svitlana Demyantes
Journal of Clinical Oncology 35 604 -604
1
2017
The fibrinogen/CRP ratio as a novel prognostic parameter for pancreatic cancer patients.
Thomas Winder , Michael Stotz , Alexander Rheinhard Siebenhuener , Konstantin Schlick
Journal of Clinical Oncology 34
2016
Inflammatory biomarkers as independent predictive and prognostic markers in metastatic colon cancer patients over several treatment lines.
Herbert Stoger , Michael Stotz , Armin Gerger , Jakob M. Riedl
Journal of Clinical Oncology 35
2017